Target intelligence / Profile preview

Host cell nuclear transcriptional machinery

Molecular classification
Enzyme, Transcription factor, Other
01

Overview

The host cell nuclear transcriptional machinery is a sophisticated assembly of enzymes and proteins, centered around RNA polymerase II, that executes the process of transcribing DNA into messenger RNA (Young, 2011, Nature). This machinery includes general transcription factors, the Mediator complex, and various chromatin-remodeling enzymes that collectively coordinate the initiation, elongation, and termination of transcription (Roeder, 2005, FEBS Letters). In the context of pathology, many viruses, such as HIV-1, HBV, and SARS-CoV-2, exploit these host proteins to express viral genes and replicate their genomes (Ott et al., 2011, Cold Spring Harbor Perspectives in Medicine). While specific components of this machinery, such as Cyclin-dependent kinase 9 (CDK9), are explored as therapeutic targets for cancer and viral infections, the fundamental necessity of transcription for all cellular life often results in significant toxicity. Consequently, drugs acting on this system often face challenges regarding their therapeutic window and potential for systemic side effects (Bensaude, 2011, Transcription).

Other names
Host transcriptional apparatusNuclear transcription complexHost transcription machineryRNA polymerase II transcription complex
02

Mechanism of action

Inhibition of RNA polymerase II processivity, DNA intercalation, or inhibition of transcriptional kinases such as CDK7 and CDK9 that regulate the transition from transcription initiation to elongation (Wang & Fischer, 2008, Trends in Pharmacological Sciences).

03

Biological functions

Cell cycleOther
04

Disease associations

CancerInfectionInflammation
05

Safety considerations

Systemic cytotoxicityNarrow therapeutic indexInhibition of essential housekeeping genesGastrointestinal and hematologic toxicity (Bensaude, 2011, Transcription)
06

Interacting drugs

Alvocidib (Flavopiridol)

5 more in the full profile.

07

Biomarkers

Phospho-RNA polymerase II (Ser2/Ser5) levelsGlobal mRNA synthesis ratesViral load (e.g., HIV-1 RNA levels)

Beyond the preview

Go deeper on Host cell nuclear transcriptional machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell nuclear transcriptional machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call